Mumbai-based healthtech startup PharmEasy has raised $50 million in a Series C round of funding led by Eight Roads Ventures India, the proprietary investment arm of Fidelity International Ltd (FIL); F-Prime Capital; Fundamentum Advisors, an investment firm backed by Nandan Nilkeni and Sanjeev Aggarwal; and San Francisco-based hedge fund Think Investments. PharmEasy plans to use the funding to build a larger consumer base and work towards improving its technology capabilities.
PharmEasy raises $50 million Series C Funding Led by Eight Roads Ventures, Others
Date posted: Wednesday 26 September 2018